SARS

TAU Scientist Awarded U.S. Patent for Novel Coronavirus Vaccine Design

By Jewish Press News Desk

The patent, approved in March, covers a vaccine that targets the most vulnerable point in a coronavirus’s structure, through which it penetrates human cells